Correction of metabolic acidosis via bicarbonate precursor effect

Correction of metabolic acidosis via bicarbonate precursor effect" is not a specific molecule, protein, or therapeutic target, but rather refers to the clinical intervention of restoring acid-base balance in cases of metabolic acidosis by administering substances (bicarbonate or its precursors) that replenish or generate bicarbonate in the body. Common agents used are sodium bicarbonate, sodium acetate, sodium lactate, and potassium citrate, which act either directly as buffers or are metabolized to yield bicarbonate. Bicarbonate therapy is particularly important in cases where the body’s bicarbonate stores are depleted due to conditions like chronic kidney disease, diarrhea, and certain types of renal tubular acidosis. However, sodium bicarbonate and other precursors are not molecular targets in the traditional sense (i.e., receptors, enzymes, channels), but exogenous compounds used to restore physiological homeostasis. Potential side effects include fluid overload, electrolyte imbalance, paradoxical CNS acidosis, and complications from over-correction or inappropriate use, particularly in patients with ongoing tissue hypoxia, lactic acidosis, or advanced vascular calcification[1][3][4][5][6][7]. This entry does not refer to a single, well-defined biological target and is best classified as an intervention strategy, not a molecular entity.

Other names

Correction of metabolic acidosisBicarbonate precursor effectBicarbonate supplementation

Buffering of excess hydrogen ions, Regeneration of bicarbonate by metabolism of organic anions, Neutralization of systemic acidaemia, Support of normal serum bicarbonate levels